You are here: Industry Insights > buprenorphine

News List

Braeburn Submits Request for Final Approval of BRIXADI for Opioid Use Disorder americanpharmaceuticalreview
June 11, 2020
Braeburn has requested final approval from the U.S. Food and Drug Administration (FDA) of the New Drug Application for BRIXADI™ (buprenorphine) weekly and monthly extended-release injection for the treatment of opioid use disorder (OUD).
Prevalence of Buprenorphine-Waivered Prescribers Increasing drugs
January 20, 2020
From 2007 to 2017, there was an increase in the prevalence of buprenorphine-waivered prescribers in the United States, according to a research letter published online January in the Annals of Internal Medicine.
One Big Roadblock to Opioid Addiction Treatment drugs
January 07, 2020
The crisis of opioid abuse continues in the United States. However, a new study finds there still aren't enough doctors authorized to prescribe the leading drug treatment for opioid addiction.
Overdose, Relapse After Buprenorphine Discontinuation High drugs
December 27, 2019
Buprenorphine treatment may be needed for several years after an opioid overdose to reduce the risk of overdose and other adverse events ...
Pharmaceutical Treatments for Opioid Abuse May Benefit Teens drugs
September 18, 2019
Teens who misuse prescription or illicit opioids might benefit from the opioid treatment medications methadone, buprenorphine, and naltrexone...
Taking Buprenorphine for Opioid Use Disorder May Up Other Med Compliance drugs
August 22, 2019
Using buprenorphine to treat opioid use disorder (OUD) may increase adherence to treatments for other chronic conditions, according to a study published in the September issue of Medical Care.
'Secret Shopper' Study Finds Many Who Need Addiction Treatment Can't Get It drugs
June 05, 2019
When people who are addicted to opioids make the difficult decision to quit, the last thing they need to face are barriers to treatment.
Many Buprenorphine Prescribers Not Offering New Appointments drugs
June 04, 2019
Many buprenorphine prescribers not offering new appointments.
Racial Disparity Seen in Prescriptions for Buprenorphine drugs
May 21, 2019
Racial Disparity Seen in Prescriptions for Buprenorphine.
Long-lasting opioid treatment recommended by an EMA committee europeanpharmaceuticalreview
May 05, 2019
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.

Previous page 1 2 Next page